von Eyss Research Group

Selected Publications

    Publications at FLI

    2019

    • Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.
      Haikala HM, Anttila JM, Marques E, Raatikainen T, Ilander M, Hakanen H, Ala-Hongisto H, Savelius M, Balboa D, Von Eyss B, Eskelinen V, Munne P, Nieminen AI, Otonkoski T, Schüler J, Laajala TD, Aittokallio T, Sihto H, Mattson J, Heikkilä P, Leidenius M, Joensuu H, Mustjoki S, Kovanen P, Eilers M, Leverson JD, Klefström J
      Nat Commun 2019, 10(1), 620
    • Publisher Correction: Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy.
      Haikala HM, Anttila JM, Marques E, Raatikainen T, Ilander M, Hakanen H, Ala-Hongisto H, Savelius M, Balboa D, Von Eyss B, Eskelinen V, Munne P, Nieminen AI, Otonkoski T, Schüler J, Laajala TD, Aittokallio T, Sihto H, Mattson J, Heikkilä P, Leidenius M, Joensuu H, Mustjoki S, Kovanen P, Eilers M, Leverson JD, Klefström J
      Nat Commun 2019, 10(1), 932
    • The Myb-MuvB Complex Is Required for YAP-Dependent Transcription of Mitotic Genes.
      Pattschull G, Walz S, Gründl M, Schwab M, Rühl E, Baluapuri A, Cindric-Vranesic A, Kneitz S, Wolf E, Ade CP, Rosenwald A, von Eyss B, Gaubatz S
      Cell Rep 2019, 27(12), 3533-3546.e7
    • Adult stem cells at work: regenerating skeletal muscle.
      Schmidt M, Schüler SC, Hüttner SS, von Eyss B, von Maltzahn J
      Cell Mol Life Sci 2019, 76(13), 2559-70

    2018

    • Author Correction: TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
      Elster D, Tollot M, Schlegelmilch K, Ori A, Rosenwald A, Sahai E, von Eyss B
      Nat Commun 2018, 9(1), 3781 Erratum for Nat Commun. 2018 volume 9 page 3115
    • TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
      Elster* D, Tollot* M, Schlegelmilch K, Ori A, Rosenwald A, Sahai E, von Eyss B
      Nat Commun 2018, 9(1), 3115 * equal contribution

    2017

    • OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors.
      Jung LA, Gebhardt A, Koelmel W, Ade CP, Walz S, Kuper J, von Eyss B, Letschert S, Redel C, d'Artista L, Biankin A, Zender L, Sauer M, Wolf E, Evan G, Kisker C, Eilers M
      Oncogene 2017, 36(14), 1911-24 published during change of institution
    • Deletion of Gas2l3 in mice leads to specific defects in cardiomyocyte cytokinesis during development.
      Stopp S, Gründl M, Fackler M, Malkmus J, Leone M, Naumann R, Frantz S, Wolf E, von Eyss B, Engel FB, Gaubatz S
      Proc Natl Acad Sci U S A 2017, 114(30), 8029-34 published during change of institution

    2016

    • TEAD activity is restrained by MYC and stratifies human breast cancer subtypes.
      Elster D, Jaenicke LA, Eilers M, von Eyss B
      Cell Cycle 2016, 15(19), 2551-6
    • Different promoter affinities account for specificity in MYC-dependent gene regulation.
      Lorenzin F, Benary U, Baluapuri A, Walz S, Jung LA, von Eyss B, Kisker C, Wolf J, Eilers M, Wolf E
      Elife 2016, 5. pii: e15161, doi: 10.7554/eLife.15161.